Browsing Tag
R327
1 post
Recce Pharmaceuticals completes cohort dosing in R327 Phase I/II trial
Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) continues its trajectory in pioneering a new class of Synthetic Antiinfectives, spotlighting its…